Last updated at 04 Nov 2025 02:26 AM
Director
DIN: 01754582
Ashish Hasmukh Shah is currently associated with 3 companies as Director. They serve as a Director at BELIEVE INTERNATIONAL LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01754582.Ashish Hasmukh Shah has previously been associated with 1 company in roles such as Additional Director.Ashish Hasmukh Shah is currently involved in 1 different role. Their most recent position is with EIGHT STAR PHARMA PRIVATE LIMITED as a Director. The first company Ashish Hasmukh Shah was appointed to as a director was BELIEVE INTERNATIONAL LIMITED. Ashish Hasmukh Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ashish Hasmukh Shah is currently associated with 3 companies as Director. They serve as a Director at BELIEVE INTERNATIONAL LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01754582.Ashish Hasmukh Shah has previously been associated with 1 company in roles such as Additional Director.Ashish Hasmukh Shah is currently involved in 1 different role. Their most recent position is with EIGHT STAR PHARMA PRIVATE LIMITED as a Director. The first company Ashish Hasmukh Shah was appointed to as a director was BELIEVE INTERNATIONAL LIMITED. Ashish Hasmukh Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (1)
1y 5m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BELIEVE INTERNATIONAL LIMITED | Director | 30-Sep-2019 |
| BELIEVE PHARMA PRIVATE LIMITED | Director | 13-Mar-2025 |
| EIGHT STAR PHARMA PRIVATE LIMITED | Director | 03-Nov-2025 |